Drug Approval | August 22, 2022
USFDA grants emergency use authorization for Novavax COVID-19 vaccine
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Lupin is the 6th largest company in the Indian Pharmaceutical Market
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Subscribe To Our Newsletter & Stay Updated
